These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 31981500)

  • 1. Readmission After Surgical Aortic Valve Replacement in the United States.
    Khoury H; Ragalie W; Sanaiha Y; Boutros H; Rudasill S; Shemin RJ; Benharash P
    Ann Thorac Surg; 2020 Sep; 110(3):849-855. PubMed ID: 31981500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thirty-Day Readmissions After Transcatheter Aortic Valve Replacement in the United States: Insights From the Nationwide Readmissions Database.
    Kolte D; Khera S; Sardar MR; Gheewala N; Gupta T; Chatterjee S; Goldsweig A; Aronow WS; Fonarow GC; Bhatt DL; Greenbaum AB; Gordon PC; Sharaf B; Abbott JD
    Circ Cardiovasc Interv; 2017 Jan; 10(1):. PubMed ID: 28034845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early readmissions after transcatheter and surgical aortic valve replacement.
    Vejpongsa P; Bhise V; Charitakis K; Vernon Anderson H; Balan P; Nguyen TC; Estrera AL; Smalling RW; Dhoble A
    Catheter Cardiovasc Interv; 2017 Oct; 90(4):662-670. PubMed ID: 28251807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends, Predictors, and Outcomes of 30-Day Readmission With Heart Failure After Transcatheter Aortic Valve Replacement: Insights From the US Nationwide Readmission Database.
    Zahid S; Din MTU; Khan MZ; Rai D; Ullah W; Sanchez-Nadales A; Elkhapery A; Khan MU; Goldsweig AM; Singla A; Fonarrow G; Balla S
    J Am Heart Assoc; 2022 Aug; 11(16):e024890. PubMed ID: 35929464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association Between Hospital Volume and 30-Day Readmissions Following Transcatheter Aortic Valve Replacement.
    Khera S; Kolte D; Gupta T; Goldsweig A; Velagapudi P; Kalra A; Tang GHL; Aronow WS; Fonarow GC; Bhatt DL; Aronow HD; Kleiman NS; Reardon M; Gordon PC; Sharaf B; Abbott JD
    JAMA Cardiol; 2017 Jul; 2(7):732-741. PubMed ID: 28494061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence, Causes, and Predictors of Early (≤30 Days) and Late Unplanned Hospital Readmissions After Transcatheter Aortic Valve Replacement.
    Nombela-Franco L; del Trigo M; Morrison-Polo G; Veiga G; Jimenez-Quevedo P; Abdul-Jawad Altisent O; Campelo-Parada F; Biagioni C; Puri R; DeLarochellière R; Dumont E; Doyle D; Paradis JM; Quirós A; Almeria C; Gonzalo N; Nuñez-Gil I; Salinas P; Mohammadi S; Escaned J; Fernández-Ortiz A; Macaya C; Rodés-Cabau J
    JACC Cardiovasc Interv; 2015 Nov; 8(13):1748-57. PubMed ID: 26476610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Etiologies and Predictors of 30-Day Readmission and In-Hospital Mortality During Primary and Readmission After Transcatheter Aortic Valve Implantation.
    Panaich SS; Arora S; Patel N; Lahewala S; Agrawal Y; Patel NJ; Shah H; Patel V; Deshmukh A; Schreiber T; Grines CL; Badheka AO
    Am J Cardiol; 2016 Dec; 118(11):1705-1711. PubMed ID: 27677388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Frequency of Late Gastrointestinal Bleeding With Transcatheter Versus Surgical Aortic Valve Replacement.
    Iyengar A; Sanaiha Y; Aguayo E; Seo YJ; Dobaria V; Toppen W; Shemin RJ; Benharash P
    Am J Cardiol; 2018 Nov; 122(10):1727-1731. PubMed ID: 30316451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and predictors of readmissions to non-index hospitals after transcatheter aortic valve replacement and the impact on in-hospital outcomes: From the nationwide readmission database.
    Ando T; Adegbala O; Villablanca P; Akintoye E; Ashraf S; Shokr M; Siddiqui F; Takagi H; Grines CL; Afonso L; Briasoulis A
    Int J Cardiol; 2019 Oct; 292():50-55. PubMed ID: 31053244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in Costs and Risk Factors of 30-Day Readmissions for Transcatheter Aortic Valve Implantation.
    Arora S; Hendrickson MJ; Strassle PD; Qamar A; Pandey A; Kolte D; Sitammagari K; Cavender MA; Fonarow GC; Bhatt DL; Vavalle JP
    Am J Cardiol; 2020 Dec; 137():89-96. PubMed ID: 32991853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying patients likely to be readmitted after transcatheter aortic valve replacement.
    Goldsweig A; Aronow HD
    Heart; 2020 Feb; 106(4):256-260. PubMed ID: 31649048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes and readmissions after transcatheter and surgical aortic valve replacement in patients with cirrhosis: A propensity matched analysis.
    Dhoble A; Bhise V; Nevah MI; Balan P; Nguyen TC; Estrera AL; Smalling RW
    Catheter Cardiovasc Interv; 2018 Jan; 91(1):90-96. PubMed ID: 28846185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hospital Variation in 30-Day Readmissions Following Transcatheter Aortic Valve Replacement.
    Kolte D; Kennedy K; Wasfy JH; Jena AB; Elmariah S
    J Am Heart Assoc; 2021 May; 10(10):e021350. PubMed ID: 33938233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcatheter Aortic Valve Implantation Readmissions in the Current Era (from the National Readmission Database).
    Tripathi B; Nerusu LA; Sawant AC; Atti L; Sharma P; Pershad A
    Am J Cardiol; 2020 Sep; 130():115-122. PubMed ID: 32665132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence, 30-day readmission rates and predictors of readmission after new onset atrial fibrillation who underwent transcatheter aortic valve replacement.
    Doshi R; Pisipati S; Taha M; Dave M; Shah J; Adalja D; Gullapalli N
    Heart Lung; 2020; 49(2):186-192. PubMed ID: 31690493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and Predictors of Readmissions to Non-Index Hospitals After Transcatheter Aortic Valve Implantation in the Contemporary Era in New South Wales, Australia.
    Shawon MSR; Ryan JB; Jorm L
    Heart Lung Circ; 2024 Jul; 33(7):1027-1035. PubMed ID: 38580581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. National trends and 30-day readmission rates for next-day-discharge transcatheter aortic valve replacement: An analysis from the Nationwide Readmissions Database, 2012-2016.
    Yerasi C; Tripathi B; Wang Y; Forrestal BJ; Case BC; Khan JM; Torguson R; Ben-Dor I; Satler LF; Garcia-Garcia HM; Weintraub WS; Rogers T; Waksman R
    Am Heart J; 2021 Jan; 231():25-31. PubMed ID: 33091365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Causes, Risk Factors, and Costs of 30-Day Readmissions After Mitral Valve Repair and Replacement.
    Goel NJ; Iyengar A; Kelly JJ; Brown CR; Kurshan F; Atluri P; Acker MA; Chen Z; Desai ND
    Ann Thorac Surg; 2019 Dec; 108(6):1729-1737. PubMed ID: 31479638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term Hospital Readmissions After Surgical Vs Transcatheter Aortic Valve Replacement.
    Bianco V; Kilic A; Gleason TG; Lee JS; Schindler J; Aranda-Michel E; Wang Y; Navid F; Kliner D; Cavalcante JL; Mulukutla SR; Sultan I
    Ann Thorac Surg; 2019 Oct; 108(4):1146-1152. PubMed ID: 31039354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health Care Resource, Economic, and Readmission Implications After Acute Decompensated Aortic Stenosis-A Nationwide Study.
    Patel KP; Sawatari H; Chahal A; Vuyisile NT; Somers V; Mullen MJ; Ricci F; Khanji MY
    Am J Cardiol; 2023 Oct; 204():200-206. PubMed ID: 37544145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.